Cargando…

Risk of infections in patients with gout: a population-based cohort study

To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (...

Descripción completa

Detalles Bibliográficos
Autores principales: Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., Joosten, L. A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431148/
https://www.ncbi.nlm.nih.gov/pubmed/28469154
http://dx.doi.org/10.1038/s41598-017-01588-5
_version_ 1783236375807524864
author Spaetgens, B.
de Vries, F.
Driessen, J. H. M.
Leufkens, H. G.
Souverein, P. C.
Boonen, A.
van der Meer, J. W. M.
Joosten, L. A. B.
author_facet Spaetgens, B.
de Vries, F.
Driessen, J. H. M.
Leufkens, H. G.
Souverein, P. C.
Boonen, A.
van der Meer, J. W. M.
Joosten, L. A. B.
author_sort Spaetgens, B.
collection PubMed
description To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD). All patients with a first diagnosis of gout and aged >40 years between January 1987-July 2014, were included and matched with up to two controls. Time-varying Cox proportional hazards models were used to estimate the risk of infections and mortality. 131,565 patients and 252,763 controls (mean age: 64 years, 74% males, mean follow-up of 6.7 years) were included in the full cohort. After full statistical adjustment, the risk of pneumonia was increased (adj. HR 1.27, 95% CI 1.18 to 1.36), while the risk of UTI (adj. HR 0.99, 95% CI 0.97 to 1.01) was similar in patients compared to controls. No differences between patients and controls were observed for infection-related mortality due to pneumonia (adj. HR 1.03, 95% CI 0.93 to 1.14) or UTI (adj. HR 1.16, 95% CI 0.98 to 1.37). In conclusion, patients with gout did not have decreased risks of pneumonia, UTI or infection-related mortality compared to population-based controls.
format Online
Article
Text
id pubmed-5431148
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54311482017-05-16 Risk of infections in patients with gout: a population-based cohort study Spaetgens, B. de Vries, F. Driessen, J. H. M. Leufkens, H. G. Souverein, P. C. Boonen, A. van der Meer, J. W. M. Joosten, L. A. B. Sci Rep Article To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD). All patients with a first diagnosis of gout and aged >40 years between January 1987-July 2014, were included and matched with up to two controls. Time-varying Cox proportional hazards models were used to estimate the risk of infections and mortality. 131,565 patients and 252,763 controls (mean age: 64 years, 74% males, mean follow-up of 6.7 years) were included in the full cohort. After full statistical adjustment, the risk of pneumonia was increased (adj. HR 1.27, 95% CI 1.18 to 1.36), while the risk of UTI (adj. HR 0.99, 95% CI 0.97 to 1.01) was similar in patients compared to controls. No differences between patients and controls were observed for infection-related mortality due to pneumonia (adj. HR 1.03, 95% CI 0.93 to 1.14) or UTI (adj. HR 1.16, 95% CI 0.98 to 1.37). In conclusion, patients with gout did not have decreased risks of pneumonia, UTI or infection-related mortality compared to population-based controls. Nature Publishing Group UK 2017-05-03 /pmc/articles/PMC5431148/ /pubmed/28469154 http://dx.doi.org/10.1038/s41598-017-01588-5 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Spaetgens, B.
de Vries, F.
Driessen, J. H. M.
Leufkens, H. G.
Souverein, P. C.
Boonen, A.
van der Meer, J. W. M.
Joosten, L. A. B.
Risk of infections in patients with gout: a population-based cohort study
title Risk of infections in patients with gout: a population-based cohort study
title_full Risk of infections in patients with gout: a population-based cohort study
title_fullStr Risk of infections in patients with gout: a population-based cohort study
title_full_unstemmed Risk of infections in patients with gout: a population-based cohort study
title_short Risk of infections in patients with gout: a population-based cohort study
title_sort risk of infections in patients with gout: a population-based cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431148/
https://www.ncbi.nlm.nih.gov/pubmed/28469154
http://dx.doi.org/10.1038/s41598-017-01588-5
work_keys_str_mv AT spaetgensb riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT devriesf riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT driessenjhm riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT leufkenshg riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT souvereinpc riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT boonena riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT vandermeerjwm riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT joostenlab riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy